Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?

Johnson, William; Mishra, Anjali; Binder, Adam; Gru, Alejandro; Porcu, Pierluigi

Johnson, William; Mishra, Anjali; Binder, Adam; Gru, Alejandro; Porcu, Pierluigi.

Afiliação

Johnson W; Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Mishra A; Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Binder A; Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Gru A; Division of Hematopathology, Department of Pathology, University of Virginia, Charlottsville, VA, USA.
Porcu P; Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.

Haematologica ; 104(5): 864-867, 2019 05.

Article em En | MEDLINE | ID: mdl-31040231

Assuntos

Leucemia-Linfoma de Células T do Adulto; Linfoma; Adulto; Anticorpos Monoclonais Humanizados; Humanos; Recidiva

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma de Células T do Adulto / Linfoma Limite: Adult / Humans Idioma: En Revista: Haematologica Ano de publicação: 2019 Tipo de documento: Article País de publicação: Itália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google